Publications by authors named "Yuka Asami"

Claim this Profile
T
TP53 gene and pathway alterations in gastric-type adenocarcinoma of the cervix.
Daiki Higuchi, Maiko Yamaguchi, Erisa Fujii, Mayumi Kobayashi Kato, Kengo Hiranuma, Yuka Asami

JNCI Cancer Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.
Shu Yazaki, Megumi Hori, Hisaki Aiba, Yukihide Momozawa, Masayuki Yoshida, Yuka Asami

EBioMedicine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer.
Maiko Miwa, Masakazu Kitagawa, Yuka Asami, Mayumi Kobayashi-Kato, Takafumi Watanabe

Cancer Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma.
Mayumi Kobayashi Kato, Erisa Fujii, Maiko Yamaguchi, Daiki Higuchi, Yuka Asami

Gynecol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma

Cancer Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer.
Mayumi Kobayashi-Kato, Erisa Fujii, Yuka Asami, Yuka Ahiko, Kengo Hiranuma

Gynecol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.
Kengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, Naoya Murakami, Yoko Shimada

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience.
Minoru Nagashima, Tetsuya Ishikawa, Yuka Asami, Yusuke Hirose, Kanae Shimada

Jpn J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer.
Yuka Asami, Mayumi Kobayashi Kato, Kengo Hiranuma, Maiko Matsuda, Yoko Shimada

Br J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
Yuka Asami, Kengo Hiranuma, Daisuke Takayanagi, Maiko Matsuda, Yoko Shimada

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic features of endometrioid-type endometrial carcinoma arising in uterine adenomyosis.
Hiroshi Yoshida, Yuka Asami, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno

Virchows Arch· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.
Mayumi Kobayashi Kato, Yuka Asami, Daisuke Takayanagi, Maiko Matsuda, Yoko Shimada

Cancer Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Magnetic Resonance Imaging versus Intraoperative Frozen Section Diagnosis for Predicting the Deep Myometrial Invasion in Endometrial Cancer: Our Experience and Literature Review.
Chiaki Iitsuka, Yuka Asami, Yusuke Hirose, Minoru Nagashima, Takashi Mimura

J Obstet Gynaecol Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.
Ikumi Kuno, Daisuke Takayanagi, Yuka Asami, Naoya Murakami, Maiko Matsuda

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.
Naoya Murakami, Yuka Asami, Hiroshi Yoshida, Daisuke Takayanagi, Sou Hirose

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix.
Daisuke Takayanagi, Sou Hirose, Ikumi Kuno, Yuka Asami, Naoya Murakami

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of the first wave of the COVID-19 pandemic on acute care hospitals in Japan.
Jung-Ho Shin, Daisuke Takada, Tetsuji Morishita, Hueiru Lin, Seiko Bun, Yuka Asami

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and reliability of the Japanese version of the kleptomania symptom assessment scale: A comparison between individuals with kleptomania and prisoners in Japan.
Yuka Asami, Kazutaka Nomura, Hironori Shimada, Hiroyo Ohishi, Masayuki Ohishi

Compr Psychiatry· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Sou Hirose, Naoya Murakami, Kazuaki Takahashi, Ikumi Kuno, Daisuke Takayanagi, Yuka Asami

Gynecol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant struma ovarii presenting with follicular carcinoma: A case report with molecular analysis.
Takafumi Tsukada, Hiroshi Yoshida, Mitsuya Ishikawa, Yuka Asami, Kouya Shiraishi

Gynecol Oncol Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Clear Cell Adenocarcinoma of the Vulva: A Case Study With Mutation Analysis and Literature Review.
Naoki Kojima, Hiroshi Yoshida, Takashi Uehara, Takeshi Ushigusa, Yuka Asami

Int J Surg Pathol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol attenuates denervation-induced muscle atrophy due to the blockade of atrogin-1 and p62 accumulation.
Yuka Asami, Miki Aizawa, Masakazu Kinoshita, Junji Ishikawa, Kunihiro Sakuma

Int J Med Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
Kanane Shimada, Koji Matsumoto, Takashi Mimura, Tetsuya Ishikawa, Jiro Munechika, Yuka Asami

Int J Clin Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Patient with Recurrent Ovarian Cancer Who Was Hypersensitive to Carboplatin Exhibited Complete Response to Gemcitabine and Nedaplatin].
Yuka Asami, Ryo Kitagawa, Moe Iiba, Asami Uenoyama, Kazunari Kondo

Gan To Kagaku Ryoho· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis